Expanded CAG RNA has recently been reported to contribute to neurotoxicity in polyglutamine (polyQ) degeneration. In this study, we showed that RNA carrying an expanded CAG repeat progressively accumulated in the cell nucleus of transgenic Drosophila that displayed degeneration. Our gene knockdown and mutant analyses demonstrated that reduction of U2AF50 function, a gene involved in RNA nuclear export, intensified nuclear accumulation of expanded CAG RNA and resulted in a concomitant exacerbation of expanded CAG RNA-mediated toxicity in vivo. We found that the human U2AF50 ortholog, U2AF65, interacted directly and specifically with expanded CAG RNA via its RRM3 domain. We further identified an RNA/protein complex that consisted of expanded CAG RNA, U2AF65 and the NXF1 nuclear export receptor. The U2AF65 protein served as an adaptor to link expanded CAG RNA to NXF1 for RNA export. Finally, we confirmed the nuclear accumulation of expanded CAG RNA in symptomatic polyQ transgenic mice and also observed a neurodevelopmental downregulation of U2AF65 protein levels in mice. Altogether, our findings demonstrate that the cell nucleus is a site where expanded CAG RNA exerts its toxicity. We also provide a novel mechanistic explanation to how perturbation of RNA nuclear export would contribute to polyQ degeneration.
INTRODUCTION
The pathogenesis of numerous degenerative brain diseases, including Alzheimer's, Parkinson's and polyglutamine (polyQ) diseases, is known to have a close association with protein misfolding (1) . PolyQ diseases are a group of dominantly inherited genetic disorders; polyQ patients display progressive cognitive and motor impairments (2) . To date, nine polyQ diseases have been identified and they include Huntington's disease (HD), spinobulbar muscular atrophy (SBMA), dentatorubropallidoluysian atrophy, Machado -Joseph disease (MJD) and various types of spinocerebellar ataxia (3) . These diseases are caused by the expansion of an existing CAG trinucleotide repeat in the open reading frame of respective disease genes (3) . As CAG is a codon for glutamine, the resultant disease proteins therefore all bear an elongated glutamine tract. There are accumulating evidence supporting the notion that polyQ domain expansion causes conformational changes of the disease proteins, which subsequently result in neurotoxicity (4) and progressive neurodegeneration (2) .
Apart from disease protein-mediated toxicity, expanded CAG repeat-containing transcripts have recently been reported to contribute to polyQ toxicity (5) . When Li et al. (5) placed CAG repeat sequences of different lengths at the 3 ′ untranslated region (3 ′ UTR) of a DsRed reporter transgene, they found that transgenic flies expressing DsRed RNA which carried an untranslated expanded CAG repeat sequence displayed progressive neurodegeneration. Similar toxicity was also observed in other expanded CAG RNA toxicity models, including Caenorhabditis elegans (6) and mice (7). Li et al. (5) further showed that overexpression of muscleblind (mbl), an alternative splicing regulator, enhanced polyQ-mediated toxicity. They also demonstrated that mbl overexpression caused an increase in the levels of expanded CAG RNA in vivo; this in turn resulted in an elevation of disease protein levels and hence led to an enhancement of polyQ toxicity in flies (5) . This study clearly demonstrates that when the expression level of expanded CAG RNA is stabilized and/ or up-regulated, polyQ toxicity would be intensified through a mechanism relating to the upregulation of disease protein expression.
It has been well reported that the impairment of cellular RNA export causes various types of diseases (8) . To date, many adaptor and receptor proteins relating to nuclear export of RNA molecules have been identified and characterized (8) . In particular, the U2 small nuclear ribonucleoprotein auxiliary factor 65 (U2AF65) has been shown to be involved in the nuclear export of mRNA (9, 10) ; whereas NXF proteins represent a receptor family that regulate cellular RNA export (11) . The NXF1 protein is the major receptor that mediates RNA export (8) ; and the U2AF65 protein facilitates RNA nuclear export by facilitating the formation of a messenger ribonucleoprotein export complex that contains both the NXF1 receptor and the RNA substrate (9, 10) . Here, we report that the NXF1/U2AF65 RNA export pathway associates with expanded CAG RNA-mediated toxicity. We found that RNA carrying expanded CAG repeat sequences accumulated in the cell nucleus of degenerating cells in vivo. We further demonstrated that the knockdown of U2AF50 (the Drosophila ortholog of U2AF65) expression intensified the accumulation of expanded CAG RNA in the nucleus and exacerbated RNAmediated toxicity. We subsequently identified an RNA/protein complex composed of expanded CAG RNA, U2AF65 and NXF1 in mammalian cells, and showed that this complex is responsible for mediating nuclear export of expanded CAG RNA. We observed that the protein levels of U2AF65 declined in mouse brains, and such reduction was accompanied with a concomitant temporal nuclear accumulation of expanded CAG RNA in symptomatic polyQ transgenic mice. Altogether, our study first reports that nuclear accumulation of expanded CAG RNA is essential for RNA-mediated toxicity in polyQ degeneration, and our findings further provide a mechanistic explanation to how expanded CAG RNA progressively accumulates in the cell nucleus during the course of degeneration in polyQ disease.
RESULTS

Reduction of U2AF50 expression promotes nuclear accumulation of expanded CAG RNA and enhances neurodegeneration
From an in vivo double-stranded RNA (dsRNA) candidate gene knockdown study (unpublished data) performed on adult Drosophila expressing the MJD protein carrying 78 glutamine residues (12), we found that the knockdown of U2AF50 (CG9998) expression enhanced degeneration ( Fig. 1A and Supplementary Material, Fig. S1 ). A similar enhancing effect was also observed in U2AF50 XR15/+ heterozygous mutant flies (9) (Supplementary Material, Fig. S2 ). Consistent with the results obtained in vivo, we also found that knockdown of U2AF65, the human ortholog of U2AF50 (13), expression enhanced cell death induced by MJDCAG 78 in mammalian cells (Supplementary Material, Fig. S3 ).
The continuity of CAG repeat has been reported to be essential for expanded CAG RNA to confer toxicity. When the expanded CAG repeat was interrupted by the non-CAG glutamine codon, CAA, in the MJD disease gene, RNA toxicity of the MJDCAA/G 78 transgene was abolished (5). However, protein toxicity was retained (5) . We therefore used the MJDCAA/G 78 transgenic line as a protein toxicity-only control in our experiments and found that the knockdown of U2AF50 expression was unable to potentiate the MJDCAA/ G 78 protein toxicity (Fig. 1A) . Similarly, knockdown of U2AF65 expression in mammalian cells did not modify polyQ protein toxicity (Supplementary Material, Fig. S3 ). Altogether, our data clearly show that U2AF50/65 is a specific modifier of RNA, but not protein, toxicity.
It has been reported that U2AF50/65 is involved in nuclear export of RNAs (9,10), we therefore investigated whether U2AF50 modulated the nucleocytoplasmic distribution of expanded CAG RNA in vivo. As with the actin control (14) , both the unexpanded MJDCAG 27 and MJDCAA/G 78 RNAs were found to distribute evenly between the nuclear and cytoplasmic compartments (Fig. 1B) . In contrast, the cytoplasmic MJDCAG 78 RNA levels were much reduced, and this came with a concomitant enrichment of the MJDCAG 78 message in the nucleus (Fig. 1B) .
We next used the DsRedCAG RNA toxicity fly model to determine whether the U2AF50 modulatory effect of polyQ toxicity was associated with expanded CAG RNA. As the CAG repeat is inserted into the 3 ′ UTR of the DsRed transgene, no polyQ protein would be expressed in this model (5) . We found that U2AF50 knockdown enhanced expanded DsRedCAG 100 RNA-induced toxicity (Fig. 1C) , and intensified nuclear accumulation of DsRedCAG 100 RNA (Fig. 1D) . However, no such modifying effect was observed in the DsRedCAG 0 control (Fig. 1C and D) . We also showed that U2AF50 only modulated expanded CAG toxicity, but not that caused by CGG expansion (Supplementary Material, Fig. S4) . Our data therefore demonstrate a specific modifying effect of U2AF50 on expanded CAG toxicity.
Expression of expanded CAG RNA does not affect nuclear export of cellular RNAs
We next determined the nucleocytoplasmic distribution of three cellular RNAs that have previously been reported to associate with U2AF50 (9), and found that nuclear export of all these RNAs was not affected in DsRedCAG 100 -expressing flies (Supplementary Material, Fig. S5 ). This indicates that U2AF50-mediated nuclear export of cellular mRNAs was not compromised by expanded CAG RNA expression. To demonstrate that the nuclear export of these RNA substrates was U2AF50-dependent, we determined the nucleocytoplasmic distribution of the target RNAs in U2AF50 knockdown flies. As expected, export of these RNA substrates was affected and all the three targets were mainly detected in the nuclear fraction (Supplementary Material, Fig. S5 ).
U2AF65 protein directly interacts with expanded CAG RNA via its RRM3 domain
As the above genetic studies showed that U2AF50 regulates the nucleocytoplasmic distribution of expanded CAG RNA, we next investigated whether the human U2AF50 ortholog, Figure 1 . Modulation of U2AF50 expression levels specifically modified expanded CAG RNA-induced toxicity and altered nucleocytoplasmic localization of expanded CAG RNA. (A) Knockdown of U2AF50 expression enhanced degeneration caused by MJDCAG 78 expression as indicated by external eye degeneration. 'Minus' represents no U2AF50 knockdown control, whereas 'U2AF50 K/D' represents flies with U2AF50 expression knocked down. (B) The unexpanded MJDCAG 27 and MJDCAA/G 78 RNAs distributed evenly between the nucleus and cytoplasm, while expanded MJDCAG 78 RNA predominantly localized in the nucleus. actin was used as loading control, while U6 and tRNA met served as nuclear and cytoplasmic fractionation controls, respectively, n ¼ 3 independent experiments. 'N' and 'C' represent nuclear and cytoplasmic fractions, respectively. 'Minus' and 'plus' represent flies with wild-type expression of U2AF50 and those with knockdown expression of U2AF50, respectively. 'NS' denotes no significance. The flies were of genotypes w; gmr-GAL4 UAS-MJDCAG 27 /+; +/+, w; gmr-GAL4 UAS-MJDCAG 27 /UAS-U2AF50-dsRNA; +/+, w; gmr-GAL4/+; UAS-MJDCAG 78 /+, w; gmr-GAL4/UAS-U2AF50-dsRNA; UAS-MJDCAG 78 /+, w; UAS-MJDCAA/G 78 /+; gmr-GAL4/+, w; UAS-MJDCAA/G 78 /UAS-U2AF50-dsRNA; gmr-GAL4 /+. (C) Expression of DsRedCAG 100 RNA caused neurodegeneration in adult Drosophila as revealed by pseudopupil assay. 'Minus' represents flies with wild-type expression of U2AF50 while 'U2AF50 K/D' represents flies with U2AF50 expression knocked down. Error bars represent +s.e.m., n ¼ 3 independent experiments. (D) The DsRedCAG 0 RNA distributed evenly between the cytoplasm and nucleus, whereas DsRedCAG 100 RNA localized predominantly in the nucleus. Primers used in the PCR analysis do not amplify the CAG repeat region of the transgene, therefore the size of both the DsRedCAG 0 and DsRedCAG 100 amplicons is the same. 'Minus' and 'plus' represent flies with wild-type expression of U2AF50, and flies with knockdown expression of U2AF50, respectively. 'Plus' represents flies with U2AF50 expression knocked down. Error bars represent +s.e.m., n ¼ 3 independent experiments. The flies were of genotypes w; gmr-GAL4 UAS-DsRedCAG 0 /+; +/+, w; gmr-GAL4 UAS-DsRedCAG 0 /UAS-U2AF50-dsRNA; +/+, w; gmr-GAL4/+; UAS-DsRedCAG 100 /+, w; gmr-GAL4/ UAS-U2AF50-dsRNA; UAS-DsRedCAG 100 /+. U2AF65, would physically interact with expanded CAG repeat RNA. To do this, we performed U2AF65 co-immunoprecipitation on both flies ( Fig. 2A ) and HEK293 cells (Fig. 2B) expressing MJDCAG RNA of different CAG lengths. Our data showed that both U2AF50 ( Fig. 2A) and U2AF65 ( Fig. 2B ) interacted only with expanded MJDCAG 78 RNA, but not the unexpanded MJDCAG 27 control. Interestingly, U2AF50/65 also failed to bind MJDCAA/G 78 RNA which carries an expanded CAG repeat, but with its CAG continuity interrupted by CAA trinucleotides ( Fig. 2A and B) . The foregoing data clearly demonstrate a physical interaction between expanded MJDCAG 78 RNA and U2AF50/65, and such an RNA/protein interaction relies on the expanded nature and continuity of the CAG repeat sequences in the RNA.
To determine whether U2AF65 would interact directly with expanded CAG RNA, we performed GST pull-down experiment by incubating in vitro transcribed CAG 78 RNA with glutathione agarose beads that carried purified GST-U2AF65 fusion protein ( Fig. 2C and D) . The detection of CAG 78 RNA in the eluate collected from GST-U2AF65-loaded beads (Fig. 2D ) demonstrated that expanded CAG RNA directly bound to U2AF65. In contrast, when we incubated the GST-U2AF65 fusion protein with in vitro transcribed CTG 78 RNA, no physical interaction between GST-U2AF65 and CTG 78 RNA was detected (Fig. 2D ). This indicates that U2AF65 does not interact with any expanded trinucleotide RNA molecules, and it interacts specifically with expanded CAG RNA.
We next attempted to identify the region in U2AF65 that is essential for its interaction with expanded CAG RNA. The U2AF65 protein carries three RNA recognition motif (RRM) domains (15), and we speculated that these domain(s) would be essential for mediating the interaction between U2AF65 and expanded CAG RNA. To determine which RRM is critical for the interaction, we generated two U2AF65 mutant constructs, one expressing U2AF65 protein lacking the two C-terminal RRM domains (U2AF65 DRRM2&3) and another one lacking the most C-terminal RRM domain (U2AF65 DRRM3; Fig. 3A ). When we performed co-immunoprecipitation on cells transfected with both MJDCAG 78 and myc-tagged U2AF65 DRRM2&3 constructs, the U2AF65 DRRM2&3 mutant protein was unable to interact with MJDCAG 78 RNA (Fig. 3A) . When the U2AF65 DRRM3 protein was used instead in the co-immunoprecipitation, again no MJDCAG 78 RNA binding was detected (Fig. 3A) . The above data suggest that the RRM3 domain is crucial for U2AF65 to interact with expanded CAG RNA. We then tested whether expression of the RRM3 domain per se would be sufficient to mediate expanded CAG RNA-binding. To do this, we generated a construct carrying only the U2AF65's RRM3 domain. As predicted, expression of the RRM3 domain alone was able to co-immunoprecipitate MJDCAG 78 RNA (Fig. 3A) . Based on the above results, we were able to confine the MJDCAG 78 RNAbinding region to the RRM3 domain on U2AF65.
U2AF65 overexpression promotes nuclear export of expanded CAG RNA
The physical interaction between U2AF65 RRM3 domain and RNA described earlier prompted us to further investigate how U2AF65 mediates the nuclear export of expanded CAG RNA. We performed nucleocytoplasmic fractionation to determine whether promoting the U2AF65/MJDCAG 78 RNA interaction would facilitate nuclear export of expanded CAG RNA in mammalian cells. We observed that the overexpression of fulllength U2AF65 facilitated nuclear export of MJDCAG 78 RNA (Fig. 3B, lanes 7 and 8) . Our data also showed that the nuclear export-promoting effect of U2AF65 was CAG repeat lengthdependent, because the nucleocytoplasmic distribution of the MJDCAG 27 control RNA remained unchanged in cells overexpressing full-length U2AF65 (Fig. 3B, lanes 3 and 4) . This is consistent with our other findings that U2AF65 did not interact with MJDCAG 27 RNA (Fig. 2B) .
To determine whether the U2AF65/MJDCAG 78 RNA interaction is necessary for U2AF65 to export expanded CAG RNA, we tested the ability of mutant U2AF65 proteins which lacked the RRM3 domain to promote nuclear export of expanded CAG RNA. As expected, expression of both U2AF65 DRRM2&3 and U2AF65 DRRM3 mutant proteins failed to facilitate nuclear export of MJDCAG 78 RNA (Fig. 3B, lanes 9 -12) . This indicates that the physical RNA/ protein interaction is indispensible for U2AF65 to facilitate MJDCAG 78 RNA export. Although we showed that the U2AF65 RRM3 domain per se was able to interact with expanded CAG RNA (Fig. 3A) , its overexpression alone was not sufficient to facilitate nuclear export of MJDCAG 78 RNA (Fig. 3B, lanes 13 and 14) . This implies that additional factor(s) should be required for U2AF65 to mediate the export of expanded CAG RNA.
It has been well documented that U2AF65 facilitates RNA export through its interaction with the export receptor NXF1. We first confirmed that full-length U2AF65 interacted with NXF1 in our model (Supplementary Material, Fig. S6 ) as previously reported (9, 10) . Although the RRM3 domain per se is sufficient to interact with MJDCAG 78 RNA (Fig. 3A) , its inability to interact with the export receptor NXF1 (Supplementary Material, Fig. S6 ) makes it incapable of mediating RNA export (Fig. 3B) . The foregoing data therefore clearly illustrate that both U2AF65 and NXF1 are necessary for mediating the nuclear export of MJDCAG 78 RNA. Expanded CAG RNA, U2AF65 and NXF1 form an RNA/protein complex We speculated that U2AF65 serves as an adaptor to link expanded CAG RNA to the NXF1 export receptor. To test this, we first asked whether MJDCAG 78 RNA, U2AF65 and NXF1 would exist in a complex. When we immunoprecipitated endogenous NXF1, we detected MJDCAG 78 RNA and U2AF65 in the immunoprecipitant (Fig. 4A) . Likewise, when we performed immunoprecipitation to capture endogenous U2AF65, both MJDCAG 78 RNA and NXF1 could be detected in the eluate (Fig. 4B ). This clearly indicates that MJDCAG 78 RNA, U2AF65 and NXF1 all existed in an RNA/protein complex. Further, when we performed NXF1 immunoprecipitation in cells treated with U2AF65 siRNA, no MJDCAG 78 RNA could be found in the eluate (Fig. 4A) . This shows that the association between MJDCAG 78 RNA and NXF1 was dependent on the existence of U2AF65. In contrast, when U2AF65 was immunoprecipitated from cells treated with NXF1 siRNA, MJDCAG 78 RNA could still be co-immunoprecipitated (Fig. 4B) . This indicates that the removal of NXF1 did not disrupt the interaction between U2AF65 and MJDCAG 78 RNA. Such result further supports our previous findings that MJDCAG 78 RNA interacts directly with U2AF65 (Fig. 2D) . Based on the foregoing data, we report the existence of a novel RNA/protein complex composed of MJDCAG 78 RNA, U2AF65 and NXF1.
It is well known that adaptor proteins are required to link cellular RNA substrates to the NXF1 export receptor (8) . The above findings show that U2AF65 serves as an adaptor to couple expanded CAG RNA to NXF1. We next investigated the RNA export functionality of this MJDCAG 78 RNA/ U2AF65/NXF1 RNA/protein complex. We found that knockdown of U2AF65 expression caused nuclear accumulation of MJDCAG 78 RNA (Fig. 4C, lanes 3 and 4 when compared with lanes 1 and 2), whereas U2AF65 overexpression promoted RNA export and resulted in cytoplasmic enrichment of MJDCAG 78 RNA in HEK293 cells (Fig. 4C, lanes 5 and 6) . This illustrates that the cellular levels of U2AF65 are pivotal to MJDCAG 78 RNA export. Similar to U2AF65 knockdown, NXF1 siRNA treatment diminished MJDCAG 78 RNA export and resulted in nuclear accumulation of expanded CAG RNA (Fig. 4C, lanes 7 and 8) .
In contrast to U2AF65, overexpression of the NXF1 receptor per se did not expedite expanded CAG RNA export (Fig. 4C,  lanes 9 and 10) . This may be explained if MJDCAG 78 RNA first needs to interact with U2AF65 before it could be linked to the NXF1 receptor for export as our data imply (Figs 3 and  4) . We also found that NXF1 overexpression did not alter the nucleocytoplasmic distribution of MJDCAG 27 and MJDCAA/ G 78 RNAs (Supplementary Material, Fig. S7 ). Finally, we showed that the nuclear export inhibitory effect caused by either U2AF65 (Fig. 4C, lanes 3 and 4) or NXF1 (Fig. 4C , lanes 7 and 8) knockdown could not be reverted by overexpression of the other protein component of the MJDCAG 78 RNA/ U2AF65/NXF1 complex (Fig. 4C, lanes 11-14 and Supplementary Material, Fig. S8 ). This again confirms that both U2AF65 and NXF1 are necessary for mediating MJDCAG 78 RNA export.
Nuclear accumulation of expanded CAG RNA and neurodevelopmental downregulation of U2AF65 protein levels in mice
We next investigated the nucleocytoplasmic distribution of expanded CAG RNA in a polyQ transgenic mouse model indicates that H-120 was not included in the reactions, n ¼ 3 independent experiments. (B) U2AF65 immunoprecipitation on MJDCAG 78 RNA-expressing HEK293 cells. 'Plus' indicates that the MC3 antibody was present in the immunoprecipitation reactions while 'minus' indicates that MC3 was not included in the reactions, n ¼ 3 independent experiments. (C) U2AF65 and NXF1 are both necessary for MJDCAG 78 RNA nuclear export. U6 and tRNA met served as nuclear and cytoplasmic fractionation controls respectively. 'NS' denotes no significance. Error bars represent +s.e.m., n ¼ 3 independent experiments. (16, 17) , and confirmed that expanded CAG RNA HttCAG 128 accumulated with time in the nucleus of R6/2 mouse brain cells (from 2 to 12 weeks; Fig. 5A ). With reference to the foregoing findings, we speculated that the nuclear accumulation of expanded CAG RNA is caused by a temporal reduction of U2AF65. We thus examined the U2AF65 protein levels in asymptomatic (2 weeks old) and symptomatic (12 weeks old) mice. We found that the U2AF65 protein levels were significantly reduced in 12-week-old symptomatic R6/2 mouse brains when compared with the 2-week-old ones (Fig. 5B) . Likewise, a similar temporal reduction of U2AF65 protein levels was also observed in wild-type mice (Fig. 5B) , indicating that such reduction occurred physiologically and was not influenced by disease transgene expression. Unlike U2AF65, we found that the NXF1 protein was maintained at a steady level at both time points examined (Fig. 5B) . Our findings unequivocally demonstrate that U2AF65 plays a key role in regulating the nuclear export of expanded CAG RNA in vivo, and its temporal reduction in levels causes accumulation of expanded CAG RNA in the cell nucleus.
DISCUSSION
In addition to protein-mediated neurodegeneration (1), chromosomal trinucleotide repeat expansion mutations also confer gain-of-function toxicity at the RNA level (18) . For example, a 3' UTR CTG repeat expansion in the DMPK gene leads to the production of an expanded CUG-containing RNA which causes myotonic dystrophy (19) . Apart from CTG expansion, CGG and CAG trinucleotide expansion have also been reported to contribute to toxicity in various neurological diseases (20) . RNAs containing expanded trinucleotide repeat may mediate dominant toxicity through sequestration of cellular factors; and such recruitment would deplete the levels of free cellular factors and hence result in cell dysfunction (20) . One example of such cellular factors is Muscleblind (Mbl), an RNA splicing factor. The Mbl protein has been reported to be sequestered by expanded CUG-containing DMPK RNA. As a result, free Mbl level is reduced which then causes cellular RNA splicing defects and hence leads to myotonic dystrophy (21) . Mbl sequestration has also been reported in cases of expanded CGG (22) and CAG (6, 7, 23) repeat-containing RNAs. This indicates protein sequestration being one common pathogenic mechanism of expanded trinucleotide repeat RNA toxicity.
In this study, we identified U2AF50 as a novel expanded CAG RNA toxicity modifier. Li et al. (5) showed that mbl could modulate the cellular level of expanded CAG RNA. Distinct from mbl modification, reduction of U2AF50 level did not affect the expression levels of both unexpanded and expanded CAG RNA (Supplementary Material, Fig. S9 ). This indicates that U2AF50 modulates RNA toxicity through a mechanism that is different from that of mbl. Moreover, we observed a similar modifying effect of U2AF50 in several independent polyQ disease models, including MJD, SBMA and HD (Supplementary Material, Fig. S4 ). This indicates that the modifying effect of U2AF50 is common to polyQ diseases. We also showed that U2AF50 does not modify expanded CGG-mediated toxicity (Supplementary Material,  Fig. S4 ). In addition, we found that U2AF65 does not interact with any expanded trinucleotide repeat RNA, and it has a specific binding affinity toward expanded CAG RNAs (Fig. 2D) . Furthermore, we did not detect any modulatory effect of U2AF50/65 on polyQ protein toxicity (Fig. 1A and  Supplementary Material, Fig. S3 ). This evidently indicates that polyQ protein toxicity is insensitive to U2AF50/65. Altogether, all of our findings show that the modifying effect of U2AF50/65 is highly specific for expanded CAG RNAs.
It has been shown that U2AF50/65 is involved in both splicing (24, 25) and nuclear export (9,10) of RNAs. As RNA splicing was previously reported to be unaffected in the DsRedCAG 100 model (5), we focused our investigation on the effect of U2AF50 on the nucleocytoplasmic localization of expanded CAG RNA. We found that reduction of U2AF50 levels led to accumulation of expanded CAG RNA in the nucleus in vivo (Fig. 1B and D) . We further performed a series of RNA/protein interaction studies to unveil the mechanistic details that U2AF50/65 exploits to modify the nucleocytoplasmic localization of expanded CAG RNA. We found that expanded CAG-containing RNA acquires the ability to interact directly with the RRM3 domain of U2AF65 ( Fig. 2C and D) . As the U2AF65 RRM3 domain was only previously reported as a protein -protein interaction domain (15) , our study provides the first evidence that domain possesses a novel RNA-binding property. It is speculated that the tertiary structure of the expanded CAG repeat-containing RNA may mimic a U2AF65 RRM3-interacting domain, which hence allows the RNA to interact with the RRM3 domain on U2AF65. After reporting the RNA-binding property of RRM3, we further showed that U2AF65 plays the role as an adaptor molecule to link the expanded CAG RNA to the RNA export receptor NXF1 (Figs 3 and 4) .
From the nucleocytoplasmic fractionation analysis of CAG RNAs (Fig. 1A and D) , we found that unexpanded CAG RNAs (DsRedCAG 0 and MJDCAG 27 ) distributed evenly between the cytoplasmic and nuclear fractions. In contrast, RNAs carrying expanded CAG repeat (DsRedCAG 100 and MJDCAG 78 ) predominantly localized to the nuclear fraction. We reason that nuclear accumulation of the expanded CAG RNA correlates with neurodegeneration. To more precisely monitor expanded CAG RNA-mediated toxicity, we made use of the GAL80 ts transgene (26) to finely control DsRedCAG 100 RNA expression in a temporal manner. When we examined the RNA nucleocytoplasmic distribution in this inducible model, DsRedCAG 100 RNA was first detected at low levels in the nuclear fraction at the 8 days post-induction (dpi) time point (Supplementary Material, Fig. S10B and C) . At this stage, no major sign of degeneration was observed (Supplementary Material, Fig. S10A and C) . As the DsRedCAG 100 RNA continued to accumulate in the nucleus from 8 to 12 dpi (Supplementary Material, Fig. S10B and C) , we also observed a concomitant progression of neuronal degeneration (Supplementary Material, Fig. S10A and C) . Consistently, we found that the enhancing effect of U2AF50 knockdown was accompanied with a nuclear enrichment of MJDCAG 78 (Fig. 1B) and DsRedCAG 100 (Fig. 1D ) RNAs. Altogether, our findings suggest that the nucleus is a site for expanded CAG RNA to exert its toxic effect. The pivotal role that U2AF65 plays in modulating nucleocytoplasmic localization of expanded CAG RNA was further consolidated in our mouse study (Fig. 5) . We found that protein expression level of U2AF65, but not NXF1, was significantly decreased with time. This clearly links the reduction of U2AF65 protein levels to the nuclear accumulation of expanded CAG RNA in symptomatic disease mouse brains.
In conclusion, our study demonstrates how expanded CAG RNAs accumulate in the nucleus. We also provide evidence to support how trinucleotide expansion confers elongated CAGcontaining RNAs the ability to interact with the RRM3 domain of U2AF65. The U2AF65 protein specifically promotes nuclear export of expanded CAG RNAs by linking them to the export receptor NXF1. However, the functionality of the expanded CAG RNA/U2AF65/NXF1 RNA/protein nuclear export complex is compromised by a physiological neurodevelopmental decline of U2AF65 expression. Such a reduction subsequently leads to an accumulation of expanded CAG RNA in the nucleus and causes RNA toxicity. Distinct from mbl, which modulates polyQ toxicity by increasing the levels of expanded CAG RNAs (5), our study describes a novel nuclear export mechanism that associates with expanded CAG RNA toxicity in the nucleus. We recently reported that expanded polyQ domain per se serves as a nuclear export signal, and perturbation of the protein nuclear export receptor exportin-1 contributes to polyQ protein toxicity (27) . Our current investigation further extends the involvement of nucleocytoplasmic transport in polyQ pathogenesis from protein to RNA toxicity. Identifying cellular proteins that interact with nuclearly accumulated expanded CAG RNAs will allow further understanding of the toxic roles of expanded CAG RNA in polyQ degeneration.
MATERIALS AND METHODS
DNA constructs
The MJDCAA/G 78 fragment was subcloned from pUAST-MJDCAA/G 78 (5) using BamHI and XhoI, a kind gift of Prof N. Bonini (University of Pennsylvania, USA), into pcDNA3.1 vector. The pCMV-NXF1 (10) was a kind gift of Prof B. Felber (NCI-Frederick, NIH, USA). The MJDCAG 78 and MJDCAG 27 fragments were subcloned from UAS-MJDCAG 78 and UAS-MJDCAG 27 flies (12) using EcoRI and NotI into pcDNA3.1 vector. For the generation of pcDNA3.1-myc-U2AF65FL, full-length U2AF65 open reading frame was first amplified from HEK293 cDNA template with primers U2AF65FLF, 5 ′ -CGG GAT CCA TGG AAC AGA AAC TCA TCT CTG AAG AGG ATC TGA TGT CGG ACT TCG ACG AGT TC-3 ′ and U2AF65FLR, 5 ′ -CGC TCG AGC TAC CAG AAG TCC CGG CGG-3 ′ and then subcloned into pcDNA3.1 vector using BamHI and XhoI. The pcDNA3.1-myc-U2AF65FL plasmid was used as template to generate various deletion constructs. Primers U2AF65FLF and U2AF65DRRM3R, 5 ′ -CGC TCG AGG TAC TCG TCG TCC AGC AGC TC-3 ′ were used to generate myc-tagged U2AF65DRRM3 insert, while U2AF65FLF and U2AF65DRRM2&3R, 5 ′ -CGC TCG AGG TAG GGG ACC ACA GTG GAC AC-3 ′ were used to generate myc-tagged U2AF65DRRM2&3 insert, and RRM3F, 5 ′ -CGG  GAT CCA TGG AAC AGA AAC TCA TCT CTG AAG AGG  ATC TGA TGG ACT GAG GTC CTG TGC CTC-3 ′ and U2AF65FLR were used to generate myc-tagged RRM3. These deletion inserts were subsequently subcloned into pcDNA3.1 vector using BamHI and XhoI. Primers GST-U2AF65F, 5
′ -CGG GAT CCA TGG AAC AGA AAC TCA TCT CTG AAG AGG ATC TGA TGT CGG ACT TCG ACG AGT TC-3 ′ and GST-U2AF65R, 5 ′ -CGC TCG AGC TAC CAG AAG TCC CGG CGG-3' were used to amplify full-length U2AF65 fragment from the pcDNA3.1-myc-U2AF65FL template, and the fragment was then subcloned into pGEX-4T3 expression vector using BamHI and XhoI to generate pGEX-4T3-U2AF65FL construct.
Drosophila stocks
Flies were raised on cornmeal medium supplement with dry yeast. Fly lines bearing UAS-DsRedCAG 0 (5), UAS-DsRedCAG 100 (5), UAS-ARCAG 112 (28), UAS-MJDCAG 27 (12) , UAS-MJDCAG 78 (12) and UAS-MJDCAA/G 78 (5) were kind gifts of Prof. N. Bonini (University of Pennsylvania, USA). The UAS-EGFPCGG 90 (29) and UAS-HttCAG 93 (30) lines were kindly provided by Prof. S. Warren (Emory University, USA) and Prof. S. Zhang (University of Texas Health Center at Houston, USA), respectively. The U2AF50 XR15 deletion mutant line (9) was kindly provided by Prof. D. Rio (University of California, Berkeley, USA). The UAS-GFPCAG 76 transgenic line was previously reported (31) . The U2AF50 UAS-dsRNA line was obtained from Vienna Drosophila RNAi Center, Austria; and the gmr-GAL4 line were obtained from Bloomington Drosophila Stock Center, USA.
Pseudopupil assay
Pseudopupil assay was performed as previously described (27, 32) . In brief, more than 200 ommatidia from at least 30 adult flies obtained from three independent crosses were used to calculate the average number of rhabdomeres per ommatidium.
Mammalian cell culture
HEK293 cells were cultured at 378C with 5% CO 2 in high glucose DMEM supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin. Transient transfection was performed using Fugene HD (Roche).
RNA fractionation, RNA extraction and semi-quantitative RT -PCR Nucleocytoplasmic fractionation of RNA was performed as previously described (33) with minor modifications. Fly head or mouse brain samples were homogenized on ice in lysis buffer [10 mM Tris -HCl pH 7.4, 140 mM NaCl, 1.5 mM MgCl 2 , 10 mM EDTA, 0.5% NP-40, 40 U RNAsin (Promega)] for 5 min. After centrifugation at 500g for 5 min at 48C, supernatants containing the cytoplasmic fraction were harvested. The nuclear pellets were rinsed twice with lysis buffer after centrifugation at 8000g for 5 min at 48C. RNA was extracted from nuclear and cytoplasmic fractions by Trizol reagent (Invitrogen) and 0.5 mg of RNA was then used to perform reverse-transcription using the ImPromII TM Reverse Transcription System (Promega). PCR reactions were performed using the following primer pairs: DsRedF,
Protein/RNA and protein/protein interactions Protein/RNA binding experiment was performed as previously described (34) ′ -TTA TGT CAG ATA AAG TGT G-3 ′ . For U2AF65/NXF1 interaction, myc-tagged U2AF proteins were immunoprecipitated by mouse anti-myc antibody 9B11
(1:250, Cell Signaling Technology). Co-immunoprecipitation was performed as previously described (27) using buffer containing 20 mM HEPES, pH 7.4, 150 mM NaCl, 5 mM MgCl 2 , 0.5% NP-40. The immunoprecipitated U2AF proteins were detected with rabbit anti-myc antibody 71D10 (1:2000, Cell Signaling Technology), while the co-immunoprecipitated NXF1 was detected with rabbit anti-NXF1 antibody H-120 (1:1500, Santa Cruz).
To examine direct protein/RNA direct interaction, GST-tagged full-length U2AF65 protein was expressed in E. coli strain BL21(DE3), and the GST-U2AF65 protein was purified using a GSTrap column (GE Healthcare). Purified GST proteins were captured by glutathione sepharose beads (GE Healthcare). CAG 78 RNA was synthesized using the MEGAscript w kit (Ambion) from PCR product amplified from pcDNA3.1-MJDCAG 78 template using primers T7CAGF, 5 ′ -TAA TAC GAC TCA CTA TAG GGA GAA GAA GCC TAC TTT GAA AAA-3 ′ and CAGR, 5 ′ -CTG TCC TGA TAG GTC CCG-3 ′ . The same methodology was used to generate CTG 78 RNA, with the exception that the PCR product used in the synthesis was amplified by primers T7CTGF, 5
′ -TAA TAC GAC TCA CTA TAG GGA GAA GAC ACG ACT ATC CAG GGC-3 ′ and CTGR, 5 ′ -CTT CGG ATG AAA CTT TTT-3 ′ . The in vitro transcribed CAG 78 and CTG 78 RNAs (10 pmol) were independently mixed with GST-or GST-U2AF65-coated glutathione sepharose beads and the mixture was incubated at 48C overnight. Prior to elution, the protein/RNA mixture was washed three times with binding buffer. Bound RNA was then extracted and followed by RT -PCR detection as described earlier.
Western blotting
The MJDQ27, MJDQ78 and MJDQ78 CAA/G proteins were detected using mouse anti-HA antibody HA-7 (1:2000, Sigma). Cleaved caspase-3 was detected using rabbit anti-caspase 3 antibody Asp175 (1:500, Cell Signaling Technology). Intact brains of R6/2 HD transgenic mice (The Jackson Laboratory, ME, USA) of appropriate ages were homogenized in ice-cold lysis buffer (20 mM Tris-HCl pH 7, 2% SDS, 50 mM DTT) and debris were cleared by centrifugation at 16 000g for 15 min at 48C. Samples were then analyzed by 12% SDS -PAGE. The U2AF65 protein was detected using mouse anti-U2AF65 antibody MC3 (1:2000, Abcam), rabbit anti-NXF1 antibody H-120 (1:1000, Santa Cruz) and mouse anti-tubulin antibody E7 (1:5000, Developmental Studies Hybridoma Bank).
Statistical analyses
Protein and DNA bands were quantified using the Image J software (Ver. 1.32; Research Services Branch, National Institute of Mental Health) or Photoshop CS2 (Adobe). The Mann -Whitney rank sum test was performed to determine mean differences when comparing results for the pseudopupil assays and temporal analysis of the U2AF65 protein levels in mice. The paired T-test was used to determine DNA band intensity difference between two groups. A P-value of ,0.05 was considered statistically significant.
